Yaashvi Jewellers IPO Day 1 Sees Tepid Demand with 2 Subscription DOE Highlights Batteries Charging and EVs Policy Focus May Shape Industry Trajectory Bond Market Signals Concern Over Feds Inflation Stance Amid Warsh Transition Tulsi Gabbard Resigns as Trump Intelligence Chief Fourth Cabinet Exit in Second Term Pentagon UFO Files Release Could Signal Shifts in Defense and Aerospace Sentiment SpaceX IPO Sector Classification Balancing Rockets Satellites and AI in SP Index CNTB Q1 2026 Earnings Significant EPS Miss as Biotech Continues PreRevenue Phase AnaptysBio Inc ANAB Q1 2026 Earnings Significant EPS Miss Amid Clinical Progress Star Bulk Carriers Corp SBLK Q1 2026 Earnings EPS Surges Past Expectations Up 24 Pyxis Tankers Q1 2026 Earnings Strong EPS Beat Amidst Soft Share Reaction CryoPort Inc CYRX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment WLY Q1 2026 Earnings EPS Beats Estimates by 1167 SKYX Platforms Stock Slides Support Test at 105 as Bearish Pressure Mounts Third Coast Bancshares TCBX Posts Modest Gains as Regional Bank Sentiment Shifts Brixmor Property Group BRX Holds Near Support as Retail REIT Faces Sector Headwinds Plexus Corp PLXS Slides 138 as Shares Approach Key Support Zone Calamos Global Total Return Fund CGO Gains 124 Approaches Key Resistance at 1460 Grabs CTO Embraces 1N Strategy in Physical AI Push Even Using Competitors Robots in the Office ASH Q1 2026 Earnings EPS Misses Estimates Slightly Shares Edge Lower CIMN Senior Notes Edge Lower Amid Stable Trading ANGO Q1 2026 Earnings Strong Profitability Surprise Drives Modest Stock Gain KTCC Q1 2026 Earnings Loss Per Share of 026 as Stock Declines Global Ship Lease Inc New GSL Q4 2025 Earnings EPS Miss Weighs on Sentiment Amid Operational Stability Singapore Stocks End Nearly Flat as STI Inches Up 002 Gainers Outpace Losers Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Restrictions The Cuba Pressure Campaign Intensifies Analysts See PreConflict Playbook Dynamics MNOV Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances